On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Roberto Giugliani

ResearcherPublications, citations & collaboration network

Roberto Giugliani is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Roberto Giugliani have?

ScholarIQindexed works

Roberto Giugliani has 1,412 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Roberto Giugliani have?

ScholarIQcitation count

Roberto Giugliani has 25,081 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Roberto Giugliani?

ScholarIQh-index

Roberto Giugliani has an h-index of 81 in OpenAlex.

What is the i10-index of Roberto Giugliani?

ScholarIQi10-index

Roberto Giugliani has an i10-index of 433 in OpenAlex.

What is the ORCID of Roberto Giugliani?

ScholarIQorcid

The ORCID for Roberto Giugliani is on the source record.

What is the OpenAlex record for Roberto Giugliani?

ScholarIQopenalex

The OpenAlex for Roberto Giugliani is on the source record.

What are the most-cited papers on Roberto Giugliani?

ScholarIQmost cited works
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
Dominique P. Germain, Derralynn Hughes, Kathy Nicholls, Daniel G. Bichet, Roberto Giugliani, William R. Wilcox, Claudio Feliciani, Suma P. Shankar, Fatih Süheyl Ezgü, Hernan Amartino, Drago Bratkovic, Ulla Feldt‐Rasmussen, Khan Nedd, Usama Sharaf El Din, Charles Marques Lourenço, Maryam Banikazemi, Joel Charrow, Majed Dasouki, David N. Finegold, Pilar Giraldo, Özlem Göker-Alpan, Nicola Longo, C. Ronald Scott, Roser Torrá, Ahmad Tuffaha, Ana Jovanović, Stephen Waldek, Seymour Packman, Elizabeth Ludington, Christopher Viereck, John Kirk, Julie Yu, Elfrida R. Benjamin, Franklin K. Johnson, David J. Lockhart, Nina Skuban, Jeff Castelli, Jay Barth, Carrolee Barlow, Raphael Schiffmann
New England Journal of Medicine. 2016560 CitationsOPEN ACCESS
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study
Christian J. Hendriksz, Barbara K. Burton, Thomas R. Fleming, Paul Harmatz, Derralynn Hughes, Simon Jones, Hsiang‐Yu Lin, Eugen Mengel, Maurizio Scarpa, Vassili Valayannopoulos, Roberto Giugliani, STRIVE Investigators, Peter Slasor, Debra L. Lounsbury, Wolfgang Dummer
Journal of Inherited Metabolic Disease. 2014211 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account